title: Which is the real efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in HCV infected patients with advanced fibrosis?
authors.forename: Adriano M
authors.initials: AM
authors.lastname: Pellicelli
authors.forename: Mario
authors.initials: M
authors.lastname: Romano
authors.forename: Paolo
authors.initials: P
authors.lastname: Guarascio
authors.forename: Pascal
authors.initials: P
authors.lastname: Vignally
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000209:etiology*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin